Malignant neoplasm of pleura
ICD-10 C38.4 is a billable code used to indicate a diagnosis of malignant neoplasm of pleura.
Malignant neoplasm of the pleura primarily refers to tumors that arise from the pleural lining of the lungs, most commonly associated with mesothelioma, which is linked to asbestos exposure. This neoplasm can present with symptoms such as pleuritic chest pain, dyspnea, and cough. Diagnosis typically involves imaging studies like chest X-rays or CT scans, followed by biopsy for histological confirmation. The pleura is a critical structure in the thoracic cavity, and malignancies here can lead to significant complications, including pleural effusion and respiratory distress. Treatment options may include surgical resection, chemotherapy, and radiation therapy, depending on the stage and extent of the disease. Surgical considerations are paramount, as complete resection can be challenging due to the tumor's invasive nature and proximity to vital thoracic structures. Multidisciplinary management is often required, involving oncologists, thoracic surgeons, and palliative care specialists to optimize patient outcomes.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Diagnosis and management of pleural mesothelioma, treatment planning for chemotherapy or radiation.
Ensure accurate staging and grading of the tumor for appropriate coding.
Operative reports, pre-operative assessments, and post-operative follow-ups are essential.
Surgical resection of pleural tumors, management of pleural effusions.
Document the extent of resection and any complications encountered during surgery.
Performed for resection of malignant pleural tumors.
Operative report detailing the extent of resection and findings.
Thoracic surgery documentation must include pre-operative assessments.
The primary cause is often exposure to asbestos, which is linked to the development of mesothelioma, the most common type of malignant pleural neoplasm.
